Adicet Bio, INC Schedule 13G passive stakes

RA Capital Management and its affiliates report maintaining a 9.9% beneficial ownership in Adicet Bio, Inc. as of June 30, 2026, primarily through RA Capital Healthcare Fund, L.P.

Woodline Partners LP has disclosed beneficial ownership of 313,124 shares, representing 3.3% of Adicet Bio, Inc.'s common stock, as of March 31, 2026.

RA Capital Management, along with its affiliates, has reported beneficial ownership of 12.3% of Adicet Bio's common stock, totaling 1,182,624 shares, as of February 17, 2026.

Franklin Resources, Inc. and its subsidiary Franklin Advisers, Inc. have reported a 6.5% beneficial ownership stake in Adicet Bio, Inc. as of December 31, 2025.

Tang Capital Management, LLC and affiliated entities have filed an amended Schedule 13G, disclosing a 9.9% beneficial ownership stake in Adicet Bio, Inc. as of March 31, 2025.